ICOS ligand costimulation is required for T-cell encephalitogenicity

被引:69
|
作者
Sporici, RA
Beswick, RL
von Allmen, C
Rumbley, CA
Hayden-Ledbetter, M
Ledbetter, JA
Perrin, PJ
机构
[1] Univ Penn, Sch Med, Dept Med, Pulm Allergy & Crit Care Sect, Philadelphia, PA 19104 USA
[2] Pacific NW Res Inst, Seattle, WA 98122 USA
关键词
EAE/MS; costimulatory molecules; T-lymphocytes; immunotherapy;
D O I
10.1006/clim.2001.5074
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The interaction of ICOS with its ligand on APC provides a costimulatory signal to previously activated T-cells. In these studies, we blocked the ICOS:ICOS ligand interaction with ICOS-Ig during the in vitro activation of AMP-reactive transgenic CD4(+) T-cells. The presence of ICOS-Ig in these cultures inhibited the ability of the transgenic T-cells to transfer EAE, although they entered the brains of the recipient mice. ICOS-Ig increased apoptosis in the transgenic T-cells, especially in the memory population. This enhanced apoptosis was accompanied by an increase in the BAX/BCL-2 mRNA ratio. ICOS-Ig did not prevent IL2 production, demonstrating that IL-2 production is ICOS ligand independent. IFN-gamma and IL-10 production by the transgenic T-cells, however, was suppressed. Finally, ICOS-Ig injection into mice after the first signs of EAE ameliorated clinical disease. Therefore, ICOS-Ig provides a signal distinct from CD28 costimulation that is required for the activation and viability of encephalitogenic T-cells. (C) 2001 Academic Press.
引用
收藏
页码:277 / 288
页数:12
相关论文
共 50 条
  • [41] T-cell immunotherapy for malignant glioma: toward a combined approach
    Dietrich, Pierre-Yves
    Dutoit, Valerie
    Nhu Nam Tran Thang
    Walker, Paul R.
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (06) : 604 - 610
  • [42] T-cell recognition of self peptides as tumor rejection antigens
    Kawakami, Y
    Rosenberg, SA
    IMMUNOLOGIC RESEARCH, 1996, 15 (03) : 179 - 190
  • [43] Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist
    Maus, Marcela V.
    Levine, Bruce L.
    ONCOLOGIST, 2016, 21 (05): : 608 - 617
  • [44] Advances in CAR-T-cell therapy in T-cell malignancies
    Zheng, Rubing
    Zhu, Xiaojian
    Xiao, Yi
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [45] Characterization of an Anti-CD5 Directed CAR T-Cell against T-Cell Malignancies
    Masayuki Wada
    Hongyu Zhang
    Liu Fang
    Jia Feng
    Charlotte Olivia Tse
    Wenli Zhang
    Qi Chen
    Sha Sha
    Yuanzhen Cao
    Kevin H. Chen
    Kevin G. Pinz
    Xi Chen
    Xing-Xing Fan
    Xun Jiang
    Yupo Ma
    Stem Cell Reviews and Reports, 2020, 16 : 369 - 384
  • [46] Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
    Caracciolo, Daniele
    Riillo, Caterina
    Ballerini, Andrea
    Gaipa, Giuseppe
    Lhermitte, Ludovic
    Rossi, Marco
    Botta, Cirino
    Duroyon, Eugenie
    Grillone, Katia
    Gallo Cantafio, Maria Eugenia
    Buracchi, Chiara
    Alampi, Greta
    Gulino, Alessandro
    Belmonte, Beatrice
    Conforti, Francesco
    Golino, Gaetanina
    Juli, Giada
    Altomare, Emanuela
    Polera, Nicoletta
    Scionti, Francesca
    Arbitrio, Mariamena
    Iannone, Michelangelo
    Martino, Massimo
    Correale, Pierpaolo
    Talarico, Gabriella
    Ghelli Luserna di Rora, Andrea
    Ferrari, Anna
    Concolino, Daniela
    Sestito, Simona
    Pensabene, Licia
    Giordano, Antonio
    Hildinger, Markus
    Di Martino, Maria Teresa
    Martinelli, Giovanni
    Tripodo, Claudio
    Asnafi, Vahid
    Biondi, Andrea
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (02)
  • [47] Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity
    Liu, Pentao
    Li, Peng
    Burke, Shannon
    IMMUNOLOGICAL REVIEWS, 2010, 238 : 138 - 149
  • [48] Tetracyclines Enhance Anti-tumor T-Cell Responses Induced by a Bispecific T-Cell Engager
    Noguchi, Yuki
    Yamamoto, Yoko
    Iwahori, Kota
    Matsumoto, Mitsunobu
    Hirata, Michinari
    Okuyama, Hiroomi
    Shintani, Yasushi
    Kumanogoh, Atsushi
    Wada, Hisashi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (04) : 429 - 437
  • [49] Immunologic Control of Human T-Cell Leukemia Virus Type I and Adult T-Cell Leukemia
    Mari Kannagi
    International Journal of Hematology, 2007, 86 : 113 - 117
  • [50] Feedback activation of T-cell antigen-presenting cells during interactions with T-cell responders
    Mannie, MD
    Walker, MR
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 70 (02) : 252 - 260